Direct effects of caffeine on osteoblastic cells metabolism: The possible causal effect of caffeine on the formation of osteoporosis

Journal of Orthopaedic Surgery and Research

Volumn 1, Issue 1, 2006, Pages

  Tsuang, Yang Hwei ^a   Sun, Jui Sheng ^a,b   Chen, Li Ting ^c   Sun, Samuel Chung Kai ^d   Chen, San Chi ^e  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Stem Cell Research Center   (Taiwan)

^d QUEEN S UNIVERSITY   (Canada)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248213011     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/1749-799X-1-7     Document Type: Article

References (36)

1. Heaney RP, Recker RR: Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab & Clin Med 1982, 99:46-55.
2. Massey LK, Wise KJ: The effect of dietary caffeine on urinary excretion of calcium, magnesium, sodium and potassium in healthy young females. Nutr Res 1984, 4:43-50.
3. Heaney RP: Effects of caffeine on bone and the calcium economy. Food Chem Toxicol 2002, 40:1263-1270.
4. Barrett-Connor E, Chang JC, Edelstein SL: Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA 1994, 271:280-283.
5. Hernandez-Avila M, Colditz GA, Stampfer MJ, Rosner B, Speizer FE, Willett WC: Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr 1991, 54:157-163.
6. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995, 332:767-773.
7. Meyer HE, Pedersen JI, Loken EB, Tverdal A: Dietary factors and the incidence of hip fracture in middle-aged Norwegians - a prospective study. Am J Epidemiol 1997, 145:117-123.
8. Smith S, Swain J, Brown EM, Wyshak G, Albright T, Ravnikar VA, Schiff I: A preliminary report of the short-term effect of car-bonated beverage consumption on calcium metabolism in normal women. Arch Intern Med 1989, 149:2517-2519.
9. Hansen MA, Overgaard K, Riis BJ, Christiansen C: Potential risk factors for development of postmenopausal osteoporosis - examined over a 12-year period. Osteoporos Int 1991, 1:95-102.
10. Cooper C, Atkinson EJ, Wahner HW, O'Fallon WM, Riggs BL, Judd HL, Melton LJ 3rd: Is caffeine consumption a risk factor for osteoporosis? J Bone Miner Res 1992, 7:465-471.
11. Reid IR, Ames RW, Evans MC, Sharpe SJ, Gamble GD: Determinants of the rate of bone loss in normal postmenopausal women. J Clin Endocrinol Metab 1994, 79:950-954.
12. Packard PT, Recker RR: Caffeine does not affect the rate of gain in spine bone in young women. Osteoporos Int 1996, 6:149-152.
13. Lloyd T, Rollings N, Eggli DF, Kieselhorst K, Chinchilli VM: Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997, 65:1826-1830.
14. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP: Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporotic Study. J Bone Miner Res 2000, 15:710-720.
15. Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL: Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001, 74:694-700.
16. Sun JS, Lin CY, Dong GC, Sheu SY, Lin FH, Chen LT, Wang YJ: The Effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on Bone Cells Activities. Biomaterials 2002, 23:3377-3385.
17. Caplan AI, Pechak DG: The cellular and molecular embryology of bone formation. Bone and mineral research, Vol. 5. Elsevier, Hall AK and Dickson IR. The effects of parathyroid hormone on asteoblast-like cell from embryonic chick calvaria. Acta Endocrinol 1985, 108:217-223.
18. Doherty MJ, Schlag G, Schwarz N, Mollan RA, Nolan PC, Wilson DJ: Biocompatibility of xenogeneic bone, commercially available coral, a bioceramic and tissue sealant for human osteoblasts. Biomaterials 1994, 15:601-608.
19. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983, 65:55-63.
20. Gundle R, Beresford JN: The isolation and culture of cells from explants of human trabecular bone. Calcif Tissue Int 1995, 56:S8-S10.
21. Dews PB: Caffeine. Ann Rev Nutr 1982, 2:323-341.
22. Sugiyama K, He P, Wada S, Saeki S: Teas and other beverages suppress D-galactosamine-induced liver injury in rats. J Nutr 1999, 129:1361-1367.
23. Kiel DP, Felson DT, Hannan MT, Anderson JJ, Wilson PW: Caffeine and the risk of hip fracture: the Framingham Study. Am J Epidemiol 1990, 132:675-684.
24. Kamagata-Kiyoura Y, Ohta M, Cheuk G, Yazdani M, Saltzman MJ, Nakamoto T: Combined effects of caffeine and prostaglandin E2 on the proliferation of osteoblast-like cells (UMRI 06-01). J Periodont 1999, 70:283-288.
25. Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G, et al.: Risk factors for hip fracture in European women: The MEDOS study. J Bone Miner Res 1995, 10:1802-1815.
26. Lloyd T, Rollings N, Eggli DF, Kieselhorst K, Chinchilli VM: Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997, 65:1826-1830.
27. Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M: Transcriptional control of osteoblast growth and differentiation. Physiol Rev 1996, 76:593-629.
28. Coelho MJ, Fernandes MH: Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycer-ophosphate and dexamethasone on osteoblastic differentiation, Biomaterials 2000, 21:1095-1102.
29. Harris SA, Enger RJ, Riggs BL, Spelsberg TC: Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 1995, 10:178-186.
30. Quinn JMW, Sabokbar A, Denne M, de Vernejoul MC, McGee JO, Athanasou NA: Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tissue Int 1997, 60:63-70.
31. Lerner UH, Ransjo M, Ljunggren O: Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro. Calcif Tissue Internat 1987, 40:323-331.
32. Desimone DP, Greene VS, Hannon KS, Turner RT, Bell NH: Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease. J Bone Miner Res 1993, 8:625-634.
33. Fuller K, Chambers TJ: Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res 1989, 4:209-215.
34. Okuda A, Taylor LM, Heersche JN: Prostaglandin E2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures. Bone Miner 1989, 7:255-266.
35. Saraste A, Pulkki K: Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000, 45:528-537.
36. Hoeberichts FA, Woltering EJ: Multiple mediators of plant programmed cell death: interplay of conserved cell death mechanisms and plant-specific regulators. BiooEssays 2003, 25:47-57.